Clinical Trial Update: KAP for Depression in Abstinent Opioid Users [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating KAP for depression in abstinent opioid users was terminated, and results were posted on 2024-05-06.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Opioid Use Disorder

Snippet

Sponsor: Medical University of South Carolina | Conditions: Opioid Use Disorder, Severe, in Sustained Remission, Opioid Use Disorder, Severe, in Early Remission | Phase 2 | Status: TERMINATED | Results posted: 2024-05-06